Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01256398
Title Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

acute lymphoblastic leukemia

Therapies

Dexamethasone

Dasatinib

Tacrolimus

Cyclophosphamide + Fludarabine

Filgrastim

Mercaptopurine + Methotrexate + Vincristine Sulfate

Melphalan

Cytarabine + Daunorubicin + Etoposide

Pegfilgrastim

Alemtuzumab

Leucovorin

Age Groups: adult
Covered Countries USA


No variant requirements are available.